YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Eye makeup ©PickPik NEXGEL (NASDAQ:NXGL) reported second-quarter 2026 revenue of $3.69 million and a net loss of $2.87 million as the healthcare products company worked through a slower-than-expected integration and commercial rollout of i…
Image source: The Motley Fool. DATE Friday, May 15, 2026 at 12 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Adam R. LevyChief Financial Officer — Ian Blackman Need a quote from a Motley Fool analyst? Email pr@fool.com TAKEAWAYS Reve…
Image source: The Motley Fool. DATE Friday, May 15, 2026 at 12 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Adam R. Levy Chief Financial Officer — Ian Blackman Need a quote from a Motley Fool analyst? Email pr@fool.com Full Conferen…
Earnings Call Insights: NEXGEL (NXGL) Q4 2025 MANAGEMENT VIEW * "On today's call, I will discuss our announcement this morning regarding the closing of our transaction to acquire Celularity's degenerative wound segment." (CEO, President &…
LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel…
Quant rankings for the upcoming earnings calendar show strength concentrated in industrials and select consumer staples and technology names, while weakness is more pronounced across industrials, health care, and materials. A total of 56 c…
Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified suite of 6 established regenerative bio…
Image source: The Motley Fool. Date Tuesday, November 11, 2025 at 4:30 p.m. ET Call participants Chief Executive Officer — Adam Levy Chief Financial Officer — Joseph F. McGuire Need a quote from a Motley Fool analyst? Email pr@fool.com Ful…
Key Points GAAP revenue rose 100.3% year over year to $2.88 million in Q2 2025 but missed analyst expectations by 6.5% (GAAP). Gross margin (GAAP) improved significantly to 43.6%, reflecting the impact of branded consumer products and high…
Earnings Call Insights: NEXGEL, Inc. (NXGL) Q2 2025 MANAGEMENT VIEW * Adam R. Levy, CEO, reported that "revenue during the quarter was approximately $2.9 million, an increase of 100% year-over-year and up slightly sequentially." Levy highl…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydr…
LANGHORNE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthc…
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript April 1, 2024 NEXGEL, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Tod…
The recent surge in official interest rates, the most substantial in 40 years, is anticipated to impact aggregate demand significantly. This could potentially result in a GDP reduction of approximately 4 percent for the current year, follo…
Gross profit margin improved sequentially to 28.2% in Q3 as compared to 15.0% in Q2 LANGHORNE, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydr…
LANGHORNE, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced…
LANGHORNE, Pa., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announce…
LANGHORNE, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Aug. 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydr…
LANGHORNE, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced…
LANGHORNE, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced…
LANGHORNE, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced…
2023first quarter revenue increased56.6% year-over-yearto $620 thousand Approximately $5.8 million in cash and securities at March 31, 2023 Provides second quarter2023 revenue guidance of $1.0 million, an increase of 78.2% year-over-year L…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydro…
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved As of December 31, 2022, had over $6.6 million in cash and securities which is sufficient to operate through 2025 LANGHORNE, Pa., March 27, 2023 (GLOBE NEW…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 15, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hyd…
Gurenlianand his training campto use NEXGEL’s Turfguardfor turf burn in lacrosse LANGHORNE, Pa., March 07, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-w…
Strategic investment in CG Labs’ revenue generating and already profitable business increases NEXGEL’s capacity, improves margins and streamlines supply chain LANGHORNE, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, N…
LANGHORNE, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Company”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced…
Revenue increased 69.6% YoY while gross profit margin improved both sequentially and YoY to 26% LANGHORNE, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle…
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydr…
LANGHORNE, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced…
Patch Will Be Available to Ophthalmologists and Optometrists in 1H 2023 Global Amblyopia Market Expected to Reach Over $6 Billion by 2027 LANGHORNE, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: N…
LANGHORNE, Pa., Oct. 04, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced…
Patients Treated with SilverSeal Experienced Significantly Less Scarring and Improved Skin Functionality Following Surgical Incision LANGHORNE, Pa., Oct. 03, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), (“NEXGEL” or the “Co…